Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-01-30

FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

FDA approved a supplemental application for GONAL-F (follitropin alfa) to update labeling and/or indications under the existing license.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gonal-F (follitropin alfa)

Snippet

SUPPL AP for GONAL-F (FOLLITROPIN ALFA)